Investors Sell CME Group (CME) on Strength After Insider Selling

Traders sold shares of CME Group Inc (NASDAQ:CME) on strength during trading hours on Monday following insider selling activity. $53.20 million flowed into the stock on the tick-up and $105.22 million flowed out of the stock on the tick-down, for a money net flow of $52.02 million out of the stock. Of all companies tracked, CME Group had the 33rd highest net out-flow for the day. CME Group traded up $2.21 for the day and closed at $191.52Specifically, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction that occurred on Thursday, October 11th. The stock was sold at an average price of $179.86, for a total value of $449,650.00. Following the completion of the transaction, the chief financial officer now owns 32,720 shares of the company’s stock, valued at approximately $5,885,019.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Jack J. Tobin sold 7,820 shares of the stock in a transaction that occurred on Wednesday, September 5th. The stock was sold at an average price of $174.87, for a total value of $1,367,483.40. Following the completion of the transaction, the chief accounting officer now directly owns 17,534 shares of the company’s stock, valued at approximately $3,066,170.58. The disclosure for this sale can be found here. In the last quarter, insiders sold 34,419 shares of company stock valued at $6,305,732. Company insiders own 0.43% of the company’s stock.

Several brokerages have recently issued reports on CME. Citigroup began coverage on CME Group in a research report on Tuesday, November 20th. They issued a “buy” rating and a $220.00 target price for the company. Berenberg Bank raised CME Group from a “hold” rating to a “buy” rating and set a $220.00 target price for the company in a research report on Tuesday, November 20th. Deutsche Bank increased their target price on CME Group from $205.00 to $206.00 and gave the stock a “buy” rating in a research report on Friday, November 16th. Bank of America reissued a “buy” rating and issued a $200.00 target price on shares of CME Group in a research report on Monday, November 5th. Finally, Wells Fargo & Co increased their target price on CME Group from $175.00 to $177.00 and gave the stock a “market perform” rating in a research report on Friday, October 26th. Four equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $190.23.

The company has a debt-to-equity ratio of 0.15, a current ratio of 1.09 and a quick ratio of 1.09. The stock has a market cap of $64.34 billion, a price-to-earnings ratio of 40.15, a P/E/G ratio of 2.20 and a beta of 0.49.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, October 25th. The financial services provider reported $1.45 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.42 by $0.03. CME Group had a return on equity of 9.18% and a net margin of 113.67%. The company had revenue of $904.20 million during the quarter, compared to analyst estimates of $910.50 million. On average, equities analysts predict that CME Group Inc will post 6.65 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 27th. Investors of record on Monday, December 10th will be given a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 1.46%. The ex-dividend date of this dividend is Friday, December 7th. CME Group’s dividend payout ratio (DPR) is presently 58.70%.

Hedge funds have recently bought and sold shares of the stock. Sun Life Financial INC boosted its stake in CME Group by 267.7% during the 2nd quarter. Sun Life Financial INC now owns 923 shares of the financial services provider’s stock valued at $151,000 after purchasing an additional 672 shares during the last quarter. Oak Ridge Investments LLC boosted its stake in CME Group by 6.2% during the 2nd quarter. Oak Ridge Investments LLC now owns 5,247 shares of the financial services provider’s stock valued at $860,000 after purchasing an additional 306 shares during the last quarter. Schwab Charles Investment Management Inc. boosted its stake in CME Group by 3.2% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 1,207,970 shares of the financial services provider’s stock valued at $198,011,000 after purchasing an additional 37,225 shares during the last quarter. Pittenger & Anderson Inc. boosted its stake in CME Group by 1.3% during the 3rd quarter. Pittenger & Anderson Inc. now owns 61,396 shares of the financial services provider’s stock valued at $10,450,000 after purchasing an additional 790 shares during the last quarter. Finally, Nisa Investment Advisors LLC boosted its stake in CME Group by 13.4% during the 3rd quarter. Nisa Investment Advisors LLC now owns 122,863 shares of the financial services provider’s stock valued at $20,912,000 after purchasing an additional 14,534 shares during the last quarter. 84.55% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: This story was reported by Transcript Daily and is owned by of Transcript Daily. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at https://transcriptdaily.com/2018/11/26/investors-sell-cme-group-cme-on-strength-after-insider-selling.html.

About CME Group (NASDAQ:CME)

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

See Also: What is the 52-week high/low?

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply